Additional Information

Description

Glycopyrrolate injection, available in a single-dose vial format with a concentration of 0.2 mg/mL, comes in packs containing 25 vials of 2 mL each. This medication belongs to the class of anticholinergic agents and is primarily used to reduce excessive salivation and respiratory secretions during surgical procedures.

By blocking acetylcholine receptors, glycopyrrolate inhibits the action of the parasympathetic nervous system, thereby decreasing glandular secretions and improving surgical field visibility.

Healthcare providers administer glycopyrrolate intravenously or intramuscularly depending on the clinical situation, ensuring rapid onset of action and effective management of perioperative secretions.

The single-dose vial packaging ensures sterility and precise dosing, essential for patient safety and infection control in medical settings. Each vial's contents are carefully measured to deliver the appropriate therapeutic effect while minimizing the risk of systemic side effects.

Monitoring patient response and vital signs post-administration is critical to adjust dosage as needed and manage potential adverse effects such as dry mouth, blurred vision, or urinary retention.